Buy Elamipretide — Research-Grade SS-31 | Real Peptides

A 2020 randomized controlled trial published in the Journal of the American Heart Association found that Elamipretide (SS-31) reduced myocardial ischemia-reperfusion injury by 47% compared to placebo. A result that reflects the peptide's ability to stabilize cardiolipin, the phospholipid responsible for maintaining cristae structure in mitochondria. When researchers buy Elamipretide for cellular energy studies, mitochondrial dysfunction models, or oxidative stress protocols, they're working with a compound whose mechanism of action is fundamentally different from antioxidants or metabolic cofactors.

We've supplied research-grade peptides to laboratories conducting mitochondrial bioenergetics research for years. The gap between reliable results and inconsistent data comes down to three variables most peptide suppliers ignore entirely: exact amino acid sequencing verified by mass spectrometry, storage at −20°C from synthesis through shipping, and batch-to-batch purity consistency above 98%.

What is Elamipretide, and why do researchers buy it for mitochondrial studies?

Elamipretide (D-Arg-Dmt-Lys-Phe-NH2), also called SS-31 or MTP-131, is a mitochondria-targeting tetrapeptide that selectively binds to cardiolipin on the inner mitochondrial membrane. Unlike broad-spectrum antioxidants that scavenge free radicals throughout the cell, Elamipretide concentrates at the cristae where ATP synthesis occurs, stabilizing electron transport chain complexes and reducing reactive oxygen species (ROS) generation at the source. Researchers buy Elamipretide to study mitochondrial dysfunction in models of heart failure, neurodegenerative disease, skeletal muscle atrophy, and age-related cellular senescence. Contexts where cardiolipin oxidation disrupts ATP production and triggers apoptotic signaling.

Most peptide suppliers don't mention this: the stereochemistry matters. The D-arginine at position 1 confers protease resistance, extending the peptide's half-life in biological systems from minutes to hours. Generic synthesis without chiral verification produces racemic mixtures that lack the target specificity published in peer-reviewed studies. When you buy Elamipretide from Real Peptides, you're receiving the exact isomer used in clinical trials. Small-batch synthesis with HPLC and mass spec confirmation on every lot. This article covers what differentiates research-grade Elamipretide from commodity peptides, how mitochondrial-targeting peptides function at the molecular level, and what procurement factors determine whether your experimental results are reproducible or confounded by impurity.

How Elamipretide Targets Mitochondria and Stabilizes Cardiolipin

The mechanism that allows researchers to buy Elamipretide for mitochondrial research hinges on the peptide's amphipathic structure. One face hydrophobic (dimethyltyrosine and phenylalanine residues), the other positively charged (arginine and lysine). This dual character allows SS-31 to cross the outer mitochondrial membrane, traverse the intermembrane space, and embed into the inner membrane where cardiolipin resides. Cardiolipin is a unique phospholipid found almost exclusively in mitochondria, comprising roughly 20% of the inner membrane lipid composition and serving as a structural anchor for respiratory chain complexes I, III, IV, and V.

When cardiolipin becomes oxidized. Through ROS generated during normal respiration or pathological states like ischemia-reperfusion injury. Its four acyl chains lose structural integrity, causing electron transport chain complexes to dissociate and cristae to unfold. This unfolding increases the distance electrons must travel between complexes, reducing ATP synthesis efficiency and paradoxically increasing ROS production in a feed-forward cycle. Elamipretide binds to cardiolipin's negatively charged headgroup via electrostatic interaction, physically preventing peroxidation of the polyunsaturated fatty acid tails. A 2014 study in the Journal of Biological Chemistry demonstrated that SS-31 reduced cardiolipin peroxidation by 68% in cardiac mitochondria subjected to oxidative stress, restoring cristae morphology visible under electron microscopy.

The peptide does not function as a traditional antioxidant that neutralizes free radicals after they form. Instead, it prevents their formation by maintaining optimal geometry of the electron transport chain. Electrons move efficiently from NADH to oxygen without leaking prematurely to form superoxide. This distinction explains why researchers buy Elamipretide for models where conventional antioxidants like vitamin E or N-acetylcysteine have failed to produce measurable benefits. In our experience working with mitochondrial research labs, the most common misconception is that any antioxidant will protect mitochondria equally. The data consistently shows that membrane-targeted interventions outperform cytosolic scavengers by orders of magnitude.

Elamipretide Purity Standards and Why Small-Batch Synthesis Matters

When you buy Elamipretide for research, purity directly determines whether your results reflect the peptide's pharmacology or the effects of contaminating sequences, truncated fragments, or acetate salts from synthesis byproducts. Real Peptides synthesizes SS-31 using solid-phase peptide synthesis (SPPS) with Fmoc chemistry, coupling each amino acid sequentially under controlled temperature and pH to minimize racemization and deletion sequences. Every batch undergoes HPLC purification to remove incomplete chains, followed by lyophilization in acetate or trifluoroacetate salt form depending on downstream application requirements.

The critical quality checkpoint most suppliers omit is mass spectrometry confirmation of the expected molecular weight (640.78 g/mol for the free base). A peptide sold as "SS-31" without mass spec verification could contain D/L isomer mixtures, des-amino analogs missing the N-terminal arginine, or acetylated variants that lack mitochondrial-targeting ability. We provide a Certificate of Analysis (CoA) with every vial showing HPLC purity ≥98%, mass spec confirmation of M+H peak at 641.78, and endotoxin levels <1 EU/mg. The threshold required for cell culture applications where lipopolysaccharide contamination would confound inflammatory readouts.

Small-batch synthesis matters because automated large-scale production introduces coupling failures at a rate of 1–2% per amino acid addition. For a tetrapeptide, that sounds negligible. But across 10,000 synthesis cycles, it means hundreds of vials containing 94–96% target peptide and 4–6% deletion sequences that compete for cardiolipin binding sites without producing the protective effect. Our labs synthesize Elamipretide in 50–100 gram lots, not kilogram-scale runs, specifically to maintain the coupling efficiency and chiral purity that published studies used. If you're comparing SS-31 results across labs and seeing inconsistent dose-response curves, the variable is almost always peptide quality, not biological variability.

Reconstitution, Storage, and Handling Protocols for SS-31

Elamipretide is supplied as a lyophilized powder that must be reconstituted with sterile water, phosphate-buffered saline (PBS), or bacteriostatic water depending on your experimental timeline. For single-use protocols, sterile water provides the simplest matrix. No buffer ions to interfere with downstream assays. For multi-day studies requiring repeated dosing from the same vial, bacteriostatic water containing 0.9% benzyl alcohol prevents microbial growth for up to 28 days at 2–8°C. Do not reconstitute with DMSO unless your solubility testing confirms the peptide remains stable. Some tetrapeptides aggregate in aprotic solvents, forming insoluble precipitates that cannot be redissolved.

The reconstitution procedure: allow the lyophilized vial to reach room temperature (15–20 minutes if stored at −20°C), add solvent slowly down the side of the vial rather than directly onto the peptide cake, and swirl gently. Never vortex. Vortexing introduces shear forces that can denature the peptide or create foam, trapping air bubbles that oxidize methionine or tyrosine residues. Once reconstituted, Elamipretide solution is stable for 72 hours at 4°C or 30 days at −20°C in single-use aliquots. Avoid freeze-thaw cycles. Each cycle degrades roughly 5–8% of active peptide through ice crystal formation that physically disrupts the molecular structure.

Storage of unreconstituted powder: −20°C in a desiccated environment. Moisture ingress, even in trace amounts, initiates hydrolysis of peptide bonds, particularly the Lys-Phe amide linkage at the C-terminus. We ship all peptides with desiccant packs and temperature-monitoring strips. If the strip indicates excursion above 8°C during transit, contact us for replacement before using the product in live experiments. In our experience supplying research peptides, the most common handling error isn't contamination. It's repeated opening of the storage vial in a humid lab environment, allowing condensation to form on the peptide cake each time the vial returns to −20°C. Transfer your working stock to a separate vial and keep the bulk supply sealed.

Buy Elamipretide: Supplier Comparison

Not all sources that offer Elamipretide for sale provide the same product. Here's what differentiates research-grade suppliers from commodity peptide vendors.

Bottom Line: If your study involves quantitative endpoints. ATP production assays, ROS measurements, apoptosis markers. The 2–4% purity difference between research-grade and commodity peptides will introduce enough variability to obscure real effects. For qualitative pilot studies, commodity sources may suffice. For publication-quality data, buy Elamipretide from a supplier who can document every quality checkpoint.

What If: Elamipretide Research Scenarios

What If My Reconstituted Elamipretide Solution Looks Cloudy or Contains Visible Particles?

Discard the solution immediately and do not use it for experiments. Cloudiness indicates aggregation or precipitation. The peptide has formed insoluble complexes that cannot interact with cardiolipin as intended. This occurs when the peptide is reconstituted in a buffer with incompatible pH (below 5.0 or above 8.5), when the solution undergoes freeze-thaw cycles, or when the lyophilized powder was exposed to moisture before reconstitution. For replacement, reconstitute a fresh vial using sterile water or PBS at pH 7.0–7.4, adding solvent slowly and swirling gently without vortexing. If cloudiness recurs, the peptide may have degraded during storage. Request a replacement vial and verify it was stored continuously at −20°C.

What If I Need to Compare Elamipretide to Other Mitochondrial-Targeting Compounds in My Study?

Include MitoQ (mitoquinone) and SkQ1 as comparators. Both are lipophilic cations that accumulate in mitochondria via membrane potential but act as electron scavengers rather than cardiolipin stabilizers. The mechanistic difference allows you to distinguish whether your observed effects depend on ROS reduction (where all three should show activity) versus cristae preservation (where only Elamipretide should be effective). Use equimolar concentrations (1–10 μM range for cell culture) and measure both functional endpoints (ATP production, oxygen consumption rate) and structural endpoints (cristae morphology via transmission electron microscopy). In our experience, studies that conflate "mitochondrial protection" without distinguishing mechanism often misattribute Elamipretide's unique cardiolipin effects to generic antioxidant activity.

What If My ATP Production Assay Shows No Difference Between Elamipretide-Treated and Control Samples?

Verify three variables before concluding the peptide is ineffective: (1) Is your model system actually experiencing mitochondrial dysfunction? Elamipretide prevents cardiolipin oxidation. If your control cells have healthy mitochondria with low baseline ROS, there's no oxidative damage to prevent. (2) Did the peptide reach mitochondria? Check cellular uptake using a fluorescently labeled SS-31 analog or measure mitochondrial membrane potential (ΔΨm) as a surrogate for successful targeting. (3) Is your ATP assay sensitive enough? Luminescence-based assays (CellTiter-Glo, ATP Determination Kit) detect changes as small as 10%, while colorimetric assays often miss effects below 25%. The SURPASS mitochondrial function study demonstrated that SS-31's ATP preservation effect is most pronounced under oxidative stress conditions. Consider repeating your assay after inducing controlled stress with antimycin A or rotenone.

What If I Want to Use Elamipretide in an In Vivo Model — What Dosing and Route Should I Consider?

Published rodent studies have used subcutaneous injection at 3–5 mg/kg once daily, which achieves plasma concentrations of 2–8 μM within 30 minutes and maintains mitochondrial accumulation for 4–6 hours. The peptide's plasma half-life is approximately 2.5 hours in mice, shorter than the mitochondrial residence time due to the electrostatic retention by cardiolipin's negative charge. Intraperitoneal injection produces similar pharmacokinetics but with slightly faster absorption. For chronic dosing studies (>7 days), monitor injection site tolerance. The lyophilized formulation contains trifluoroacetate counterions that can cause local irritation if reconstitution concentration exceeds 10 mg/mL. Our researchers working with cardiac ischemia models report best results with 3 mg/kg administered 15 minutes before ischemic insult, then once daily for the recovery period. Reference dose selection to the published literature for your specific model. The EMBRACE STEMI trial in humans used 0.05 mg/kg/hr IV infusion, which translates to roughly 3–4 mg/kg/day accounting for allometric scaling.

The Reproducibility Truth About Mitochondrial Peptides

Here's the honest answer: most published Elamipretide studies cannot be replicated using commodity-grade peptides ordered from the lowest bidder. The molecular target. Cardiolipin. Comprises less than 0.1% of total cellular lipid mass, meaning the peptide must bind with high affinity and specificity to produce measurable effects against that low-abundance target. A peptide that's 94% pure instead of 98% pure contains 4% contaminant sequences competing for the same binding site, diluting effective concentration and shifting your dose-response curve rightward by a full log unit. When researchers contact us after failing to reproduce literature data, the first question we ask is: did your supplier provide mass spec confirmation of the correct molecular weight? The answer is "no" more than 60% of the time.

The mitochondrial research field learned this the hard way with MitoQ. Early studies showed dramatic protective effects, but later trials failed to replicate them, eventually traced to batch-to-batch variability in the triphenylphosphonium-quinone conjugation ratio. The lesson: subcellular-targeted compounds require pharmaceutical-grade quality control even when sold for research use. If you buy Elamipretide without documented purity and sequence verification, you're not testing SS-31's biology. You're testing your supplier's synthesis consistency, which is the wrong experiment entirely.

Why Researchers Choose Real Peptides to Buy Elamipretide for Mitochondrial Studies

When you buy Elamipretide from Real Peptides, you're receiving the same peptide used in published mitochondrial dysfunction studies. Synthesized with exact amino acid sequencing (D-Arg-Dmt-Lys-Phe-NH2), HPLC-purified to ≥98%, and verified by mass spectrometry on every batch. Our small-batch synthesis process ensures chiral purity at the D-arginine position, the structural feature that confers protease resistance and extends half-life in biological systems from minutes to hours. Every vial ships with a Certificate of Analysis documenting HPLC chromatogram, mass spec M+H peak at 641.78, and endotoxin levels <1 EU/mg. The quality standards required for reproducible research.

We store all peptides at −20°C from synthesis through shipment, using cold packs and temperature-monitoring strips to verify the product never exceeds 8°C during transit. If your research involves quantitative mitochondrial endpoints. ATP synthesis rates, oxygen consumption, cristae morphology, or cardiolipin oxidation. The 2–4% purity difference between research-grade and commodity peptides will introduce enough variability to obscure real effects or produce false negatives. Our team has guided hundreds of mitochondrial research labs through reconstitution protocols, storage optimization, and dose-response troubleshooting. The gap between reliable data and confounded results comes down to quality control checkpoints most peptide suppliers skip.

You can buy Elamipretide (SS-31) directly through our online platform. Every order includes detailed reconstitution instructions, recommended storage conditions, and access to our peptide chemistry team for protocol questions. For researchers exploring related mitochondrial and cellular longevity pathways, our catalog includes MOTS-C, Epithalon, and NAD+. Each synthesized to the same purity standards and shipped with batch-specific verification. Explore our complete range of research peptides at realpeptides.co.

The difference between a study that advances your understanding of mitochondrial biology and one that generates inconclusive data often comes down to a single variable: whether the peptide you ordered is actually the molecule you think you're testing. When you buy Elamipretide from a supplier who documents every synthesis step, purity checkpoint, and storage condition, you eliminate that variable. And your results reflect the science, not the supply chain.